ELEVATION WEALTH PARTNERS, LLC
Position in ROIV — Roivant Sciences Ltd.
CIK 1976256
WALNUT CREEK, CA
Position in ROIV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,069
+$1,992 QoQ
Shares Held
115
+53.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#438
of 494 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ELEVATION WEALTH PARTNERS, LLC holds $407,446 across 28 Biotechnology names. ROIV ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,971 | $218,840 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
55 | $27,320 | |
| 3 | RPRX |
Royalty Pharma plc
|
486 | $27,250 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
101 | $24,337 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
176 | $15,303 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
1,500 | $13,132 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16 | $9,976 | |
| 8 | INCY |
Incyte Corp
|
74 | $8,388 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,069 | 115 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,077 | 75 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,627 | 75 | Shares | Sole | 2026-01-09 | |
| No filing history on record for this holder in this stock. | ||||||